CD274 and neoplasm: Therefore, blocking the PD-1/PD-L1 axis will have a synergistic therapeutic action when co-administered with DCs vaccine therapy, thus affecting the tumor microenvironment, decreasing IL-10, interferon-γ, and enhancing the function of cytotoxic T lymphocytes (98).